What Happened?
Palo Alto, CA-based Eiger BioPharmaceuticals Appointed David Cory as Chief Executive Officer
About the Company
Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. Eiger`s pipeline includes preclinical NCEs from discovery as well repurposed clinical Rx agents shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses.
About the Person
David Cory is Chief Executive Officer at Eiger BioPharmaceuticals. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile